001package org.hl7.fhir.dstu3.model.codesystems; 002 003/*- 004 * #%L 005 * org.hl7.fhir.dstu3 006 * %% 007 * Copyright (C) 2014 - 2019 Health Level 7 008 * %% 009 * Licensed under the Apache License, Version 2.0 (the "License"); 010 * you may not use this file except in compliance with the License. 011 * You may obtain a copy of the License at 012 * 013 * http://www.apache.org/licenses/LICENSE-2.0 014 * 015 * Unless required by applicable law or agreed to in writing, software 016 * distributed under the License is distributed on an "AS IS" BASIS, 017 * WITHOUT WARRANTIES OR CONDITIONS OF ANY KIND, either express or implied. 018 * See the License for the specific language governing permissions and 019 * limitations under the License. 020 * #L% 021 */ 022 023 024/* 025 Copyright (c) 2011+, HL7, Inc. 026 All rights reserved. 027 028 Redistribution and use in source and binary forms, with or without modification, 029 are permitted provided that the following conditions are met: 030 031 * Redistributions of source code must retain the above copyright notice, this 032 list of conditions and the following disclaimer. 033 * Redistributions in binary form must reproduce the above copyright notice, 034 this list of conditions and the following disclaimer in the documentation 035 and/or other materials provided with the distribution. 036 * Neither the name of HL7 nor the names of its contributors may be used to 037 endorse or promote products derived from this software without specific 038 prior written permission. 039 040 THIS SOFTWARE IS PROVIDED BY THE COPYRIGHT HOLDERS AND CONTRIBUTORS "AS IS" AND 041 ANY EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, THE IMPLIED 042 WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE ARE DISCLAIMED. 043 IN NO EVENT SHALL THE COPYRIGHT HOLDER OR CONTRIBUTORS BE LIABLE FOR ANY DIRECT, 044 INDIRECT, INCIDENTAL, SPECIAL, EXEMPLARY, OR CONSEQUENTIAL DAMAGES (INCLUDING, BUT 045 NOT LIMITED TO, PROCUREMENT OF SUBSTITUTE GOODS OR SERVICES; LOSS OF USE, DATA, OR 046 PROFITS; OR BUSINESS INTERRUPTION) HOWEVER CAUSED AND ON ANY THEORY OF LIABILITY, 047 WHETHER IN CONTRACT, STRICT LIABILITY, OR TORT (INCLUDING NEGLIGENCE OR OTHERWISE) 048 ARISING IN ANY WAY OUT OF THE USE OF THIS SOFTWARE, EVEN IF ADVISED OF THE 049 POSSIBILITY OF SUCH DAMAGE. 050 051*/ 052 053// Generated on Sat, Mar 25, 2017 21:03-0400 for FHIR v3.0.0 054 055 056import org.hl7.fhir.exceptions.FHIRException; 057 058public enum V3ObservationInterpretation { 059 060 /** 061 * Codes that specify interpretation of genetic analysis, such as "positive", "negative", "carrier", "responsive", etc. 062 */ 063 _GENETICOBSERVATIONINTERPRETATION, 064 /** 065 * The patient is considered as carrier based on the testing results. A carrier is an individual who carries an altered form of a gene which can lead to having a child or offspring in future generations with a genetic disorder. 066 */ 067 CAR, 068 /** 069 * The patient is considered as carrier based on the testing results. A carrier is an individual who carries an altered form of a gene which can lead to having a child or offspring in future generations with a genetic disorder. 070 071 072 073 Deprecation Comment: 074 This code is currently the same string as the print name for this concept and is inconsistent with the conventions being used for the other codes in the coding system, as it is a full word with initial capitalization, rather than an all upper case mnemonic. The recommendation from OO is to deprecate the code "Carrier" and to add "CAR" as the new active code representation for this concept. 075 */ 076 CARRIER, 077 /** 078 * Interpretations of change of quantity and/or severity. At most one of B or W and one of U or D allowed. 079 */ 080 _OBSERVATIONINTERPRETATIONCHANGE, 081 /** 082 * The current result or observation value has improved compared to the previous result or observation value (the change is significant as defined in the respective test procedure). 083 084 [Note: This can be applied to quantitative or qualitative observations.] 085 */ 086 B, 087 /** 088 * The current result has decreased from the previous result for a quantitative observation (the change is significant as defined in the respective test procedure). 089 */ 090 D, 091 /** 092 * The current result has increased from the previous result for a quantitative observation (the change is significant as defined in the respective test procedure). 093 */ 094 U, 095 /** 096 * The current result or observation value has degraded compared to the previous result or observation value (the change is significant as defined in the respective test procedure). 097 098 [Note: This can be applied to quantitative or qualitative observations.] 099 */ 100 W, 101 /** 102 * Technical exceptions resulting in the inability to provide an interpretation. At most one allowed. Does not imply normality or severity. 103 */ 104 _OBSERVATIONINTERPRETATIONEXCEPTIONS, 105 /** 106 * The result is below the minimum detection limit (the test procedure or equipment is the limiting factor). 107 108 Synonyms: Below analytical limit, low off scale. 109 */ 110 LESS_THAN, 111 /** 112 * The result is above the maximum quantifiable limit (the test procedure or equipment is the limiting factor). 113 114 Synonyms: Above analytical limit, high off scale. 115 */ 116 GREATER_THAN, 117 /** 118 * A valid result cannot be obtained for the specified component / analyte due to the presence of anti-complementary substances in the sample. 119 120 121 122 Deprecation Comment: 123 This code is being deprecated to match the status in V2 Table 0078 "Interpretation Codes. 124 */ 125 AC, 126 /** 127 * There is insufficient evidence that the species in question is a good target for therapy with the drug. A categorical interpretation is not possible. 128 129 [Note: A MIC with "IE" and/or a comment may be reported (without an accompanying S, I or R-categorization).] 130 */ 131 IE, 132 /** 133 * A result cannot be considered valid for the specified component / analyte or organism due to failure in the quality control testing component. 134 135 136 137 Deprecation Comment: 138 This code is being deprecated to match the status in V2 Table 0078 "Interpretation Codes. 139 */ 140 QCF, 141 /** 142 * A valid result cannot be obtained for the specified organism or cell line due to the presence of cytotoxic substances in the sample or culture. 143 144 145 146 Deprecation Comment: 147 This code is being deprecated to match the status in V2 Table 0078 "Interpretation Codes. 148 */ 149 TOX, 150 /** 151 * Interpretation of normality or degree of abnormality (including critical or "alert" level). Concepts in this category are mutually exclusive, i.e., at most one is allowed. 152 */ 153 _OBSERVATIONINTERPRETATIONNORMALITY, 154 /** 155 * The result or observation value is outside the reference range or expected norm (as defined for the respective test procedure). 156 157 [Note: Typically applies to non-numeric results.] 158 */ 159 A, 160 /** 161 * The result or observation value is outside a reference range or expected norm at a level at which immediate action should be considered for patient safety (as defined for the respective test procedure). 162 163 [Note: Typically applies to non-numeric results. Analogous to critical/panic limits for numeric results.] 164 */ 165 AA, 166 /** 167 * The result for a quantitative observation is above a reference level at which immediate action should be considered for patient safety (as defined for the respective test procedure). 168 169 Synonym: Above upper panic limits. 170 */ 171 HH, 172 /** 173 * The result for a quantitative observation is below a reference level at which immediate action should be considered for patient safety (as defined for the respective test procedure). 174 175 Synonym: Below lower panic limits. 176 */ 177 LL, 178 /** 179 * The result for a quantitative observation is above the upper limit of the reference range (as defined for the respective test procedure). 180 181 Synonym: Above high normal 182 */ 183 H, 184 /** 185 * A test result that is significantly higher than the reference (normal) or therapeutic interval, but has not reached the critically high value and might need special attention, as defined by the laboratory or the clinician.[Note: This level is situated between 'H' and 'HH'.] 186 187 188 Deprecation Comment: The code 'H>' is being deprecated in order to align with the use of the code 'HU' for "Very high" in V2 Table 0078 "Interpretation Codes". 189 190 [Note: The use of code 'H>' is non-preferred, as this code is deprecated and on track to be retired; use code 'HU' instead. 191 */ 192 H_, 193 /** 194 * A test result that is significantly higher than the reference (normal) or therapeutic interval, but has not reached the critically high value and might need special attention, as defined by the laboratory or the clinician. 195 */ 196 HU, 197 /** 198 * The result for a quantitative observation is below the lower limit of the reference range (as defined for the respective test procedure). 199 200 Synonym: Below low normal 201 */ 202 L, 203 /** 204 * A test result that is significantly lower than the reference (normal) or therapeutic interval, but has not reached the critically low value and might need special attention, as defined by the laboratory or the clinician.[Note: This level is situated between 'L' and 'LL'.] 205 206 207 Deprecation Comment: The code 'L<' is being deprecated in order to align with the use of the code 'LU' for "Very low" in V2 Table 0078 "Interpretation Codes". 208 209 [Note: The use of code 'L<' is non-preferred, as this code is deprecated and on track to be retired; use code 'LU' instead. 210 */ 211 L_, 212 /** 213 * A test result that is significantly lower than the reference (normal) or therapeutic interval, but has not reached the critically low value and might need special attention, as defined by the laboratory or the clinician. 214 */ 215 LU, 216 /** 217 * The result or observation value is within the reference range or expected norm (as defined for the respective test procedure). 218 219 [Note: Applies to numeric or non-numeric results.] 220 */ 221 N, 222 /** 223 * Interpretations of anti-microbial susceptibility testing results (microbiology). At most one allowed. 224 */ 225 _OBSERVATIONINTERPRETATIONSUSCEPTIBILITY, 226 /** 227 * Bacterial strain inhibited in vitro by a concentration of an antimicrobial agent that is associated with uncertain therapeutic effect. Reference: CLSI (http://www.clsi.org/Content/NavigationMenu/Resources/HarmonizedTerminologyDatabase/Harmonized_Terminolo.htm) 228Projects: ISO 20776-1, ISO 20776-2 229 230 [Note 1: Bacterial strains are categorized as intermediate by applying the appropriate breakpoints in a defined phenotypic test system.] 231 232 [Note 2: This class of susceptibility implies that an infection due to the isolate can be appropriately treated in body sites where the drugs are physiologically concentrated or when a high dosage of drug can be used.] 233 234 [Note 3: This class also indicates a "buffer zone," to prevent small, uncontrolled, technical factors from causing major discrepancies in interpretations.] 235 236 [Note 4: These breakpoints can be altered due to changes in circumstances (e.g., changes in commonly used drug dosages, emergence of new resistance mechanisms).] 237 */ 238 I, 239 /** 240 * The patient is considered as carrier based on the testing results. A carrier is an individual who carries an altered form of a gene which can lead to having a child or offspring in future generations with a genetic disorder. 241 242 243 244 Deprecation Comment: 245 This antimicrobial susceptibility test interpretation concept is recommended by OO to be deprecated as it is no longer recommended for use in susceptibility testing by CLSI (reference CLSI document M100-S22; Vol. 32 No.3; CLSI Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Second Informational Supplement. Jan 2012). 246 */ 247 MS, 248 /** 249 * A category used for isolates for which only a susceptible interpretive criterion has been designated because of the absence or rare occurrence of resistant strains. Isolates that have MICs above or zone diameters below the value indicated for the susceptible breakpoint should be reported as non-susceptible. 250 251 NOTE 1: An isolate that is interpreted as non-susceptible does not necessarily mean that the isolate has a resistance mechanism. It is possible that isolates with MICs above the susceptible breakpoint that lack resistance mechanisms may be encountered within the wild-type distribution subsequent to the time the susceptible-only breakpoint is set. 252 253 NOTE 2: For strains yielding results in the "nonsusceptible" category, organism identification and antimicrobial susceptibility test results should be confirmed. 254 255 Synonym: decreased susceptibility. 256 */ 257 NS, 258 /** 259 * Bacterial strain inhibited in vitro by a concentration of an antimicrobial agent that is associated with a high likelihood of therapeutic failure. 260Reference: CLSI (http://www.clsi.org/Content/NavigationMenu/Resources/HarmonizedTerminologyDatabase/Harmonized_Terminolo.htm) 261Projects: ISO 20776-1, ISO 20776-2 262 263 [Note 1: Bacterial strains are categorized as resistant by applying the appropriate breakpoints in a defined phenotypic test system.] 264 265 [Note 2: This breakpoint can be altered due to changes in circumstances (e.g., changes in commonly used drug dosages, emergence of new resistance mechanisms).] 266 */ 267 R, 268 /** 269 * A category for isolates where the bacteria (e.g. enterococci) are not susceptible in vitro to a combination therapy (e.g., high-level aminoglycoside and cell wall active agent). This is predictive that this combination therapy will not be effective. 270 271 272 Usage Note: Since the use of penicillin or ampicillin alone often results in treatment failure of serious enterococcal or other bacterial infections, combination therapy is usually indicated to enhance bactericidal activity. The synergy between a cell wall active agent (such as penicillin, ampicillin, or vancomycin) and an aminoglycoside (such as gentamicin, kanamycin or streptomycin) is best predicted by screening for high-level bacterial resistance to the aminoglycoside. 273 274 275 Open Issue: The print name of the code is very general and the description is very specific to a pair of classes of agents, which may lead to confusion of these concepts in the future should other synergies be found. 276 */ 277 SYNR, 278 /** 279 * Bacterial strain inhibited by in vitro concentration of an antimicrobial agent that is associated with a high likelihood of therapeutic success. 280Reference: CLSI (http://www.clsi.org/Content/NavigationMenu/Resources/HarmonizedTerminologyDatabase/Harmonized_Terminolo.htm) 281Synonym (earlier term): Sensitive Projects: ISO 20776-1, ISO 20776-2 282 283 [Note 1: Bacterial strains are categorized as susceptible by applying the appropriate breakpoints in a defined phenotypic system.] 284 285 [Note 2: This breakpoint can be altered due to changes in circumstances (e.g., changes in commonly used drug dosages, emergence of new resistance mechanisms).] 286 */ 287 S, 288 /** 289 * A category that includes isolates with antimicrobial agent minimum inhibitory concentrations (MICs) that approach usually attainable blood and tissue levels and for which response rates may be lower than for susceptible isolates. 290 291 Reference: CLSI document M44-A2 2009 "Method for antifungal disk diffusion susceptibility testing of yeasts; approved guideline - second edition" - page 2. 292 */ 293 SDD, 294 /** 295 * A category for isolates where the bacteria (e.g. enterococci) are susceptible in vitro to a combination therapy (e.g., high-level aminoglycoside and cell wall active agent). This is predictive that this combination therapy will be effective. 296 297 298 Usage Note: Since the use of penicillin or ampicillin alone often results in treatment failure of serious enterococcal or other bacterial infections, combination therapy is usually indicated to enhance bactericidal activity. The synergy between a cell wall active agent (such as penicillin, ampicillin, or vancomycin) and an aminoglycoside (such as gentamicin, kanamycin or streptomycin) is best predicted by screening for high-level bacterial resistance to the aminoglycoside. 299 300 301 Open Issue: The print name of the code is very general and the description is very specific to a pair of classes of agents, which may lead to confusion of these concepts in the future should other synergies be found. 302 */ 303 SYNS, 304 /** 305 * The patient is considered as carrier based on the testing results. A carrier is an individual who carries an altered form of a gene which can lead to having a child or offspring in future generations with a genetic disorder. 306 307 308 309 Deprecation Comment: 310 This antimicrobial susceptibility test interpretation concept is recommended by OO to be deprecated as it is no longer recommended for use in susceptibility testing by CLSI (reference CLSI document M100-S22; Vol. 32 No.3; CLSI Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Second Informational Supplement. Jan 2012). 311 */ 312 VS, 313 /** 314 * The observation/test result is interpreted as being outside the inclusion range for a particular protocol within which the result is being reported. 315 316 317 Example: A positive result on a Hepatitis screening test. 318 Open Issue: EX, HX, LX: These three concepts do not seem to meet a clear need in the vocabulary, and their use in observation interpretation appears likely to be covered by other existing concepts (e.g., A, H, L). The only apparent significant difference is their reference to use in protocols for exclusion of study subjects. 319These concepts/codes were proposed by RCRIM for use in the CTLaboratory message. They were submitted and approved in the November 2005 Harmonization cycle in proposal "030103C_VOCAB_RCRIM_l_quade_RCRIM Obs Interp_20051028154455". However, this proposal was not fully implemented in the vocabulary. The proposal recommended creation of the x_ClinicalResearchExclusion domain in ObservationInterpretation with a value set including those three concepts/codes, but there is no subdomain of that name or equivalent with a binding to either of the value sets that contain these concepts/codes. 320Members of the OO WG have recently attempted to contact members of RCRIM regarding these concepts, both by email and at the recent WGM in Atlanta, without response. It is felt by OO that the best course of action to take at this time is to add this comprehensive Open Issue rather than deprecate these three concepts at this time, until further discussion is held. 321 */ 322 EX, 323 /** 324 * The observation/test result is interpreted as being outside the inclusion range for a particular protocol within which the result is being reported. 325 326 327 Example: A positive result on a Hepatitis screening test. 328 Open Issue: EX, HX, LX: These three concepts do not seem to meet a clear need in the vocabulary, and their use in observation interpretation appears likely to be covered by other existing concepts (e.g., A, H, L). The only apparent significant difference is their reference to use in protocols for exclusion of study subjects. These concepts/codes were proposed by RCRIM for use in the CTLaboratory message. They were submitted and approved in the November 2005 Harmonization cycle in proposal "030103C_VOCAB_RCRIM_l_quade_RCRIM Obs Interp_20051028154455". However, this proposal was not fully implemented in the vocabulary. The proposal recommended creation of the x_ClinicalResearchExclusion domain in ObservationInterpretation with a value set including those three concepts/codes, but there is no subdomain of that name or equivalent with a binding to either of the value sets that contain these concepts/codes. Members of the OO WG have recently attempted to contact members of RCRIM regarding these concepts, both by email and at the recent WGM in Atlanta, without response. It is felt by OO that the best course of action to take at this time is to add this comprehensive Open Issue rather than deprecate these three concepts at this time, until further discussion is held. 329 */ 330 HX, 331 /** 332 * The numeric observation/test result is interpreted as being below the low threshold value for a particular protocol within which the result is being reported. 333 334 Example: A Total White Blood Cell Count falling below a protocol-defined threshold value of 3000/mm^3 335 Open Issue: EX, HX, LX: These three concepts do not seem to meet a clear need in the vocabulary, and their use in observation interpretation appears likely to be covered by other existing concepts (e.g., A, H, L). The only apparent significant difference is their reference to use in protocols for exclusion of study subjects. These concepts/codes were proposed by RCRIM for use in the CTLaboratory message. They were submitted and approved in the November 2005 Harmonization cycle in proposal "030103C_VOCAB_RCRIM_l_quade_RCRIM Obs Interp_20051028154455". However, this proposal was not fully implemented in the vocabulary. The proposal recommended creation of the x_ClinicalResearchExclusion domain in ObservationInterpretation with a value set including those three concepts/codes, but there is no subdomain of that name or equivalent with a binding to either of the value sets that contain these concepts/codes. Members of the OO WG have recently attempted to contact members of RCRIM regarding these concepts, both by email and at the recent WGM in Atlanta, without response. It is felt by OO that the best course of action to take at this time is to add this comprehensive Open Issue rather than deprecate these three concepts at this time, until further discussion is held. 336 */ 337 LX, 338 /** 339 * Hold for Medical Review 340 341 342 Usage Note: This code is not intended for use in V3 artifacts. It is included in the code system to maintain alignment with the V2 Table 0078 "Interpretation Codes." 343 */ 344 HM, 345 /** 346 * Interpretations of the presence or absence of a component / analyte or organism in a test or of a sign in a clinical observation. In keeping with laboratory data processing practice, these concepts provide a categorical interpretation of the "meaning" of the quantitative value for the same observation. 347 */ 348 OBSERVATIONINTERPRETATIONDETECTION, 349 /** 350 * The specified component / analyte, organism or clinical sign could neither be declared positive / negative nor detected / not detected by the performed test or procedure. 351 352 353 Usage Note: For example, if the specimen was degraded, poorly processed, or was missing the required anatomic structures, then "indeterminate" (i.e. "cannot be determined") is the appropriate response, not "equivocal". 354 */ 355 IND, 356 /** 357 * The test or procedure was successfully performed, but the results are borderline and can neither be declared positive / negative nor detected / not detected according to the current established criteria. 358 */ 359 E, 360 /** 361 * An absence finding of the specified component / analyte, organism or clinical sign based on the established threshold of the performed test or procedure. 362 363 [Note: Negative does not necessarily imply the complete absence of the specified item.] 364 */ 365 NEG, 366 /** 367 * The presence of the specified component / analyte, organism or clinical sign could not be determined within the limit of detection of the performed test or procedure. 368 */ 369 ND, 370 /** 371 * A presence finding of the specified component / analyte, organism or clinical sign based on the established threshold of the performed test or procedure. 372 */ 373 POS, 374 /** 375 * The measurement of the specified component / analyte, organism or clinical sign above the limit of detection of the performed test or procedure. 376 */ 377 DET, 378 /** 379 * Interpretation of the observed result taking into account additional information (contraindicators) about the patient's situation. Concepts in this category are mutually exclusive, i.e., at most one is allowed. 380 */ 381 OBSERVATIONINTERPRETATIONEXPECTATION, 382 /** 383 * This result has been evaluated in light of known contraindicators. Once those contraindicators have been taken into account the result is determined to be "Expected" (e.g., presence of drugs in a patient that is taking prescription medication for pain management). 384 */ 385 EXP, 386 /** 387 * This result has been evaluated in light of known contraindicators. Once those contraindicators have been taken into account the result is determined to be "Unexpected" (e.g., presence of non-prescribed drugs in a patient that is taking prescription medication for pain management). 388 */ 389 UNE, 390 /** 391 * Interpretation qualifiers in separate OBX segments 392 393 394 Usage Note: This code is not intended for use in V3 artifacts. It is included in the code system to maintain alignment with the V2 Table 0078 "Interpretation Codes." 395 */ 396 OBX, 397 /** 398 * Interpretations of the presence and level of reactivity of the specified component / analyte with the reagent in the performed laboratory test. 399 */ 400 REACTIVITYOBSERVATIONINTERPRETATION, 401 /** 402 * An absence finding used to indicate that the specified component / analyte did not react measurably with the reagent. 403 */ 404 NR, 405 /** 406 * A presence finding used to indicate that the specified component / analyte reacted with the reagent above the reliably measurable limit of the performed test. 407 */ 408 RR, 409 /** 410 * A weighted presence finding used to indicate that the specified component / analyte reacted with the reagent, but below the reliably measurable limit of the performed test. 411 */ 412 WR, 413 /** 414 * added to help the parsers 415 */ 416 NULL; 417 public static V3ObservationInterpretation fromCode(String codeString) throws FHIRException { 418 if (codeString == null || "".equals(codeString)) 419 return null; 420 if ("_GeneticObservationInterpretation".equals(codeString)) 421 return _GENETICOBSERVATIONINTERPRETATION; 422 if ("CAR".equals(codeString)) 423 return CAR; 424 if ("Carrier".equals(codeString)) 425 return CARRIER; 426 if ("_ObservationInterpretationChange".equals(codeString)) 427 return _OBSERVATIONINTERPRETATIONCHANGE; 428 if ("B".equals(codeString)) 429 return B; 430 if ("D".equals(codeString)) 431 return D; 432 if ("U".equals(codeString)) 433 return U; 434 if ("W".equals(codeString)) 435 return W; 436 if ("_ObservationInterpretationExceptions".equals(codeString)) 437 return _OBSERVATIONINTERPRETATIONEXCEPTIONS; 438 if ("<".equals(codeString)) 439 return LESS_THAN; 440 if (">".equals(codeString)) 441 return GREATER_THAN; 442 if ("AC".equals(codeString)) 443 return AC; 444 if ("IE".equals(codeString)) 445 return IE; 446 if ("QCF".equals(codeString)) 447 return QCF; 448 if ("TOX".equals(codeString)) 449 return TOX; 450 if ("_ObservationInterpretationNormality".equals(codeString)) 451 return _OBSERVATIONINTERPRETATIONNORMALITY; 452 if ("A".equals(codeString)) 453 return A; 454 if ("AA".equals(codeString)) 455 return AA; 456 if ("HH".equals(codeString)) 457 return HH; 458 if ("LL".equals(codeString)) 459 return LL; 460 if ("H".equals(codeString)) 461 return H; 462 if ("H>".equals(codeString)) 463 return H_; 464 if ("HU".equals(codeString)) 465 return HU; 466 if ("L".equals(codeString)) 467 return L; 468 if ("L<".equals(codeString)) 469 return L_; 470 if ("LU".equals(codeString)) 471 return LU; 472 if ("N".equals(codeString)) 473 return N; 474 if ("_ObservationInterpretationSusceptibility".equals(codeString)) 475 return _OBSERVATIONINTERPRETATIONSUSCEPTIBILITY; 476 if ("I".equals(codeString)) 477 return I; 478 if ("MS".equals(codeString)) 479 return MS; 480 if ("NS".equals(codeString)) 481 return NS; 482 if ("R".equals(codeString)) 483 return R; 484 if ("SYN-R".equals(codeString)) 485 return SYNR; 486 if ("S".equals(codeString)) 487 return S; 488 if ("SDD".equals(codeString)) 489 return SDD; 490 if ("SYN-S".equals(codeString)) 491 return SYNS; 492 if ("VS".equals(codeString)) 493 return VS; 494 if ("EX".equals(codeString)) 495 return EX; 496 if ("HX".equals(codeString)) 497 return HX; 498 if ("LX".equals(codeString)) 499 return LX; 500 if ("HM".equals(codeString)) 501 return HM; 502 if ("ObservationInterpretationDetection".equals(codeString)) 503 return OBSERVATIONINTERPRETATIONDETECTION; 504 if ("IND".equals(codeString)) 505 return IND; 506 if ("E".equals(codeString)) 507 return E; 508 if ("NEG".equals(codeString)) 509 return NEG; 510 if ("ND".equals(codeString)) 511 return ND; 512 if ("POS".equals(codeString)) 513 return POS; 514 if ("DET".equals(codeString)) 515 return DET; 516 if ("ObservationInterpretationExpectation".equals(codeString)) 517 return OBSERVATIONINTERPRETATIONEXPECTATION; 518 if ("EXP".equals(codeString)) 519 return EXP; 520 if ("UNE".equals(codeString)) 521 return UNE; 522 if ("OBX".equals(codeString)) 523 return OBX; 524 if ("ReactivityObservationInterpretation".equals(codeString)) 525 return REACTIVITYOBSERVATIONINTERPRETATION; 526 if ("NR".equals(codeString)) 527 return NR; 528 if ("RR".equals(codeString)) 529 return RR; 530 if ("WR".equals(codeString)) 531 return WR; 532 throw new FHIRException("Unknown V3ObservationInterpretation code '"+codeString+"'"); 533 } 534 public String toCode() { 535 switch (this) { 536 case _GENETICOBSERVATIONINTERPRETATION: return "_GeneticObservationInterpretation"; 537 case CAR: return "CAR"; 538 case CARRIER: return "Carrier"; 539 case _OBSERVATIONINTERPRETATIONCHANGE: return "_ObservationInterpretationChange"; 540 case B: return "B"; 541 case D: return "D"; 542 case U: return "U"; 543 case W: return "W"; 544 case _OBSERVATIONINTERPRETATIONEXCEPTIONS: return "_ObservationInterpretationExceptions"; 545 case LESS_THAN: return "<"; 546 case GREATER_THAN: return ">"; 547 case AC: return "AC"; 548 case IE: return "IE"; 549 case QCF: return "QCF"; 550 case TOX: return "TOX"; 551 case _OBSERVATIONINTERPRETATIONNORMALITY: return "_ObservationInterpretationNormality"; 552 case A: return "A"; 553 case AA: return "AA"; 554 case HH: return "HH"; 555 case LL: return "LL"; 556 case H: return "H"; 557 case H_: return "H>"; 558 case HU: return "HU"; 559 case L: return "L"; 560 case L_: return "L<"; 561 case LU: return "LU"; 562 case N: return "N"; 563 case _OBSERVATIONINTERPRETATIONSUSCEPTIBILITY: return "_ObservationInterpretationSusceptibility"; 564 case I: return "I"; 565 case MS: return "MS"; 566 case NS: return "NS"; 567 case R: return "R"; 568 case SYNR: return "SYN-R"; 569 case S: return "S"; 570 case SDD: return "SDD"; 571 case SYNS: return "SYN-S"; 572 case VS: return "VS"; 573 case EX: return "EX"; 574 case HX: return "HX"; 575 case LX: return "LX"; 576 case HM: return "HM"; 577 case OBSERVATIONINTERPRETATIONDETECTION: return "ObservationInterpretationDetection"; 578 case IND: return "IND"; 579 case E: return "E"; 580 case NEG: return "NEG"; 581 case ND: return "ND"; 582 case POS: return "POS"; 583 case DET: return "DET"; 584 case OBSERVATIONINTERPRETATIONEXPECTATION: return "ObservationInterpretationExpectation"; 585 case EXP: return "EXP"; 586 case UNE: return "UNE"; 587 case OBX: return "OBX"; 588 case REACTIVITYOBSERVATIONINTERPRETATION: return "ReactivityObservationInterpretation"; 589 case NR: return "NR"; 590 case RR: return "RR"; 591 case WR: return "WR"; 592 default: return "?"; 593 } 594 } 595 public String getSystem() { 596 return "http://hl7.org/fhir/v3/ObservationInterpretation"; 597 } 598 public String getDefinition() { 599 switch (this) { 600 case _GENETICOBSERVATIONINTERPRETATION: return "Codes that specify interpretation of genetic analysis, such as \"positive\", \"negative\", \"carrier\", \"responsive\", etc."; 601 case CAR: return "The patient is considered as carrier based on the testing results. A carrier is an individual who carries an altered form of a gene which can lead to having a child or offspring in future generations with a genetic disorder."; 602 case CARRIER: return "The patient is considered as carrier based on the testing results. A carrier is an individual who carries an altered form of a gene which can lead to having a child or offspring in future generations with a genetic disorder.\r\n\n \n \n Deprecation Comment: \n This code is currently the same string as the print name for this concept and is inconsistent with the conventions being used for the other codes in the coding system, as it is a full word with initial capitalization, rather than an all upper case mnemonic. The recommendation from OO is to deprecate the code \"Carrier\" and to add \"CAR\" as the new active code representation for this concept."; 603 case _OBSERVATIONINTERPRETATIONCHANGE: return "Interpretations of change of quantity and/or severity. At most one of B or W and one of U or D allowed."; 604 case B: return "The current result or observation value has improved compared to the previous result or observation value (the change is significant as defined in the respective test procedure).\r\n\n [Note: This can be applied to quantitative or qualitative observations.]"; 605 case D: return "The current result has decreased from the previous result for a quantitative observation (the change is significant as defined in the respective test procedure)."; 606 case U: return "The current result has increased from the previous result for a quantitative observation (the change is significant as defined in the respective test procedure)."; 607 case W: return "The current result or observation value has degraded compared to the previous result or observation value (the change is significant as defined in the respective test procedure).\r\n\n [Note: This can be applied to quantitative or qualitative observations.]"; 608 case _OBSERVATIONINTERPRETATIONEXCEPTIONS: return "Technical exceptions resulting in the inability to provide an interpretation. At most one allowed. Does not imply normality or severity."; 609 case LESS_THAN: return "The result is below the minimum detection limit (the test procedure or equipment is the limiting factor).\r\n\n Synonyms: Below analytical limit, low off scale."; 610 case GREATER_THAN: return "The result is above the maximum quantifiable limit (the test procedure or equipment is the limiting factor).\r\n\n Synonyms: Above analytical limit, high off scale."; 611 case AC: return "A valid result cannot be obtained for the specified component / analyte due to the presence of anti-complementary substances in the sample.\r\n\n \n \n Deprecation Comment: \n This code is being deprecated to match the status in V2 Table 0078 \"Interpretation Codes."; 612 case IE: return "There is insufficient evidence that the species in question is a good target for therapy with the drug. A categorical interpretation is not possible.\r\n\n [Note: A MIC with \"IE\" and/or a comment may be reported (without an accompanying S, I or R-categorization).]"; 613 case QCF: return "A result cannot be considered valid for the specified component / analyte or organism due to failure in the quality control testing component.\r\n\n \n \n Deprecation Comment: \n This code is being deprecated to match the status in V2 Table 0078 \"Interpretation Codes."; 614 case TOX: return "A valid result cannot be obtained for the specified organism or cell line due to the presence of cytotoxic substances in the sample or culture.\r\n\n \n \n Deprecation Comment: \n This code is being deprecated to match the status in V2 Table 0078 \"Interpretation Codes."; 615 case _OBSERVATIONINTERPRETATIONNORMALITY: return "Interpretation of normality or degree of abnormality (including critical or \"alert\" level). Concepts in this category are mutually exclusive, i.e., at most one is allowed."; 616 case A: return "The result or observation value is outside the reference range or expected norm (as defined for the respective test procedure).\r\n\n [Note: Typically applies to non-numeric results.]"; 617 case AA: return "The result or observation value is outside a reference range or expected norm at a level at which immediate action should be considered for patient safety (as defined for the respective test procedure).\r\n\n [Note: Typically applies to non-numeric results. Analogous to critical/panic limits for numeric results.]"; 618 case HH: return "The result for a quantitative observation is above a reference level at which immediate action should be considered for patient safety (as defined for the respective test procedure).\r\n\n Synonym: Above upper panic limits."; 619 case LL: return "The result for a quantitative observation is below a reference level at which immediate action should be considered for patient safety (as defined for the respective test procedure).\r\n\n Synonym: Below lower panic limits."; 620 case H: return "The result for a quantitative observation is above the upper limit of the reference range (as defined for the respective test procedure).\r\n\n Synonym: Above high normal"; 621 case H_: return "A test result that is significantly higher than the reference (normal) or therapeutic interval, but has not reached the critically high value and might need special attention, as defined by the laboratory or the clinician.[Note: This level is situated between 'H' and 'HH'.]\r\n\n \n Deprecation Comment: The code 'H>' is being deprecated in order to align with the use of the code 'HU' for \"Very high\" in V2 Table 0078 \"Interpretation Codes\".\r\n\n [Note: The use of code 'H>' is non-preferred, as this code is deprecated and on track to be retired; use code 'HU' instead."; 622 case HU: return "A test result that is significantly higher than the reference (normal) or therapeutic interval, but has not reached the critically high value and might need special attention, as defined by the laboratory or the clinician."; 623 case L: return "The result for a quantitative observation is below the lower limit of the reference range (as defined for the respective test procedure).\r\n\n Synonym: Below low normal"; 624 case L_: return "A test result that is significantly lower than the reference (normal) or therapeutic interval, but has not reached the critically low value and might need special attention, as defined by the laboratory or the clinician.[Note: This level is situated between 'L' and 'LL'.]\r\n\n \n Deprecation Comment: The code 'L<' is being deprecated in order to align with the use of the code 'LU' for \"Very low\" in V2 Table 0078 \"Interpretation Codes\".\r\n\n [Note: The use of code 'L<' is non-preferred, as this code is deprecated and on track to be retired; use code 'LU' instead."; 625 case LU: return "A test result that is significantly lower than the reference (normal) or therapeutic interval, but has not reached the critically low value and might need special attention, as defined by the laboratory or the clinician."; 626 case N: return "The result or observation value is within the reference range or expected norm (as defined for the respective test procedure).\r\n\n [Note: Applies to numeric or non-numeric results.]"; 627 case _OBSERVATIONINTERPRETATIONSUSCEPTIBILITY: return "Interpretations of anti-microbial susceptibility testing results (microbiology). At most one allowed."; 628 case I: return "Bacterial strain inhibited in vitro by a concentration of an antimicrobial agent that is associated with uncertain therapeutic effect. Reference: CLSI (http://www.clsi.org/Content/NavigationMenu/Resources/HarmonizedTerminologyDatabase/Harmonized_Terminolo.htm)\nProjects: ISO 20776-1, ISO 20776-2\r\n\n [Note 1: Bacterial strains are categorized as intermediate by applying the appropriate breakpoints in a defined phenotypic test system.]\r\n\n [Note 2: This class of susceptibility implies that an infection due to the isolate can be appropriately treated in body sites where the drugs are physiologically concentrated or when a high dosage of drug can be used.]\r\n\n [Note 3: This class also indicates a \"buffer zone,\" to prevent small, uncontrolled, technical factors from causing major discrepancies in interpretations.]\r\n\n [Note 4: These breakpoints can be altered due to changes in circumstances (e.g., changes in commonly used drug dosages, emergence of new resistance mechanisms).]"; 629 case MS: return "The patient is considered as carrier based on the testing results. A carrier is an individual who carries an altered form of a gene which can lead to having a child or offspring in future generations with a genetic disorder.\r\n\n \n \n Deprecation Comment: \n This antimicrobial susceptibility test interpretation concept is recommended by OO to be deprecated as it is no longer recommended for use in susceptibility testing by CLSI (reference CLSI document M100-S22; Vol. 32 No.3; CLSI Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Second Informational Supplement. Jan 2012)."; 630 case NS: return "A category used for isolates for which only a susceptible interpretive criterion has been designated because of the absence or rare occurrence of resistant strains. Isolates that have MICs above or zone diameters below the value indicated for the susceptible breakpoint should be reported as non-susceptible.\r\n\n NOTE 1: An isolate that is interpreted as non-susceptible does not necessarily mean that the isolate has a resistance mechanism. It is possible that isolates with MICs above the susceptible breakpoint that lack resistance mechanisms may be encountered within the wild-type distribution subsequent to the time the susceptible-only breakpoint is set. \r\n\n NOTE 2: For strains yielding results in the \"nonsusceptible\" category, organism identification and antimicrobial susceptibility test results should be confirmed.\r\n\n Synonym: decreased susceptibility."; 631 case R: return "Bacterial strain inhibited in vitro by a concentration of an antimicrobial agent that is associated with a high likelihood of therapeutic failure.\nReference: CLSI (http://www.clsi.org/Content/NavigationMenu/Resources/HarmonizedTerminologyDatabase/Harmonized_Terminolo.htm) \nProjects: ISO 20776-1, ISO 20776-2\r\n\n [Note 1: Bacterial strains are categorized as resistant by applying the appropriate breakpoints in a defined phenotypic test system.]\r\n\n [Note 2: This breakpoint can be altered due to changes in circumstances (e.g., changes in commonly used drug dosages, emergence of new resistance mechanisms).]"; 632 case SYNR: return "A category for isolates where the bacteria (e.g. enterococci) are not susceptible in vitro to a combination therapy (e.g., high-level aminoglycoside and cell wall active agent). This is predictive that this combination therapy will not be effective. \r\n\n \n Usage Note: Since the use of penicillin or ampicillin alone often results in treatment failure of serious enterococcal or other bacterial infections, combination therapy is usually indicated to enhance bactericidal activity. The synergy between a cell wall active agent (such as penicillin, ampicillin, or vancomycin) and an aminoglycoside (such as gentamicin, kanamycin or streptomycin) is best predicted by screening for high-level bacterial resistance to the aminoglycoside.\r\n\n \n Open Issue: The print name of the code is very general and the description is very specific to a pair of classes of agents, which may lead to confusion of these concepts in the future should other synergies be found."; 633 case S: return "Bacterial strain inhibited by in vitro concentration of an antimicrobial agent that is associated with a high likelihood of therapeutic success.\nReference: CLSI (http://www.clsi.org/Content/NavigationMenu/Resources/HarmonizedTerminologyDatabase/Harmonized_Terminolo.htm)\nSynonym (earlier term): Sensitive Projects: ISO 20776-1, ISO 20776-2\r\n\n [Note 1: Bacterial strains are categorized as susceptible by applying the appropriate breakpoints in a defined phenotypic system.]\r\n\n [Note 2: This breakpoint can be altered due to changes in circumstances (e.g., changes in commonly used drug dosages, emergence of new resistance mechanisms).]"; 634 case SDD: return "A category that includes isolates with antimicrobial agent minimum inhibitory concentrations (MICs) that approach usually attainable blood and tissue levels and for which response rates may be lower than for susceptible isolates.\r\n\n Reference: CLSI document M44-A2 2009 \"Method for antifungal disk diffusion susceptibility testing of yeasts; approved guideline - second edition\" - page 2."; 635 case SYNS: return "A category for isolates where the bacteria (e.g. enterococci) are susceptible in vitro to a combination therapy (e.g., high-level aminoglycoside and cell wall active agent). This is predictive that this combination therapy will be effective. \r\n\n \n Usage Note: Since the use of penicillin or ampicillin alone often results in treatment failure of serious enterococcal or other bacterial infections, combination therapy is usually indicated to enhance bactericidal activity. The synergy between a cell wall active agent (such as penicillin, ampicillin, or vancomycin) and an aminoglycoside (such as gentamicin, kanamycin or streptomycin) is best predicted by screening for high-level bacterial resistance to the aminoglycoside.\r\n\n \n Open Issue: The print name of the code is very general and the description is very specific to a pair of classes of agents, which may lead to confusion of these concepts in the future should other synergies be found."; 636 case VS: return "The patient is considered as carrier based on the testing results. A carrier is an individual who carries an altered form of a gene which can lead to having a child or offspring in future generations with a genetic disorder.\r\n\n \n \n Deprecation Comment: \n This antimicrobial susceptibility test interpretation concept is recommended by OO to be deprecated as it is no longer recommended for use in susceptibility testing by CLSI (reference CLSI document M100-S22; Vol. 32 No.3; CLSI Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Second Informational Supplement. Jan 2012)."; 637 case EX: return "The observation/test result is interpreted as being outside the inclusion range for a particular protocol within which the result is being reported.\n\r\n\n Example: A positive result on a Hepatitis screening test.\n Open Issue: EX, HX, LX: These three concepts do not seem to meet a clear need in the vocabulary, and their use in observation interpretation appears likely to be covered by other existing concepts (e.g., A, H, L). The only apparent significant difference is their reference to use in protocols for exclusion of study subjects.\nThese concepts/codes were proposed by RCRIM for use in the CTLaboratory message. They were submitted and approved in the November 2005 Harmonization cycle in proposal \"030103C_VOCAB_RCRIM_l_quade_RCRIM Obs Interp_20051028154455\". However, this proposal was not fully implemented in the vocabulary. The proposal recommended creation of the x_ClinicalResearchExclusion domain in ObservationInterpretation with a value set including those three concepts/codes, but there is no subdomain of that name or equivalent with a binding to either of the value sets that contain these concepts/codes.\nMembers of the OO WG have recently attempted to contact members of RCRIM regarding these concepts, both by email and at the recent WGM in Atlanta, without response. It is felt by OO that the best course of action to take at this time is to add this comprehensive Open Issue rather than deprecate these three concepts at this time, until further discussion is held."; 638 case HX: return "The observation/test result is interpreted as being outside the inclusion range for a particular protocol within which the result is being reported.\n\r\n\n Example: A positive result on a Hepatitis screening test.\n Open Issue: EX, HX, LX: These three concepts do not seem to meet a clear need in the vocabulary, and their use in observation interpretation appears likely to be covered by other existing concepts (e.g., A, H, L). The only apparent significant difference is their reference to use in protocols for exclusion of study subjects. These concepts/codes were proposed by RCRIM for use in the CTLaboratory message. They were submitted and approved in the November 2005 Harmonization cycle in proposal \"030103C_VOCAB_RCRIM_l_quade_RCRIM Obs Interp_20051028154455\". However, this proposal was not fully implemented in the vocabulary. The proposal recommended creation of the x_ClinicalResearchExclusion domain in ObservationInterpretation with a value set including those three concepts/codes, but there is no subdomain of that name or equivalent with a binding to either of the value sets that contain these concepts/codes. Members of the OO WG have recently attempted to contact members of RCRIM regarding these concepts, both by email and at the recent WGM in Atlanta, without response. It is felt by OO that the best course of action to take at this time is to add this comprehensive Open Issue rather than deprecate these three concepts at this time, until further discussion is held."; 639 case LX: return "The numeric observation/test result is interpreted as being below the low threshold value for a particular protocol within which the result is being reported.\r\n\n Example: A Total White Blood Cell Count falling below a protocol-defined threshold value of 3000/mm^3\n Open Issue: EX, HX, LX: These three concepts do not seem to meet a clear need in the vocabulary, and their use in observation interpretation appears likely to be covered by other existing concepts (e.g., A, H, L). The only apparent significant difference is their reference to use in protocols for exclusion of study subjects. These concepts/codes were proposed by RCRIM for use in the CTLaboratory message. They were submitted and approved in the November 2005 Harmonization cycle in proposal \"030103C_VOCAB_RCRIM_l_quade_RCRIM Obs Interp_20051028154455\". However, this proposal was not fully implemented in the vocabulary. The proposal recommended creation of the x_ClinicalResearchExclusion domain in ObservationInterpretation with a value set including those three concepts/codes, but there is no subdomain of that name or equivalent with a binding to either of the value sets that contain these concepts/codes. Members of the OO WG have recently attempted to contact members of RCRIM regarding these concepts, both by email and at the recent WGM in Atlanta, without response. It is felt by OO that the best course of action to take at this time is to add this comprehensive Open Issue rather than deprecate these three concepts at this time, until further discussion is held."; 640 case HM: return "Hold for Medical Review\r\n\n \n Usage Note: This code is not intended for use in V3 artifacts. It is included in the code system to maintain alignment with the V2 Table 0078 \"Interpretation Codes.\""; 641 case OBSERVATIONINTERPRETATIONDETECTION: return "Interpretations of the presence or absence of a component / analyte or organism in a test or of a sign in a clinical observation. In keeping with laboratory data processing practice, these concepts provide a categorical interpretation of the \"meaning\" of the quantitative value for the same observation."; 642 case IND: return "The specified component / analyte, organism or clinical sign could neither be declared positive / negative nor detected / not detected by the performed test or procedure.\r\n\n \n Usage Note: For example, if the specimen was degraded, poorly processed, or was missing the required anatomic structures, then \"indeterminate\" (i.e. \"cannot be determined\") is the appropriate response, not \"equivocal\"."; 643 case E: return "The test or procedure was successfully performed, but the results are borderline and can neither be declared positive / negative nor detected / not detected according to the current established criteria."; 644 case NEG: return "An absence finding of the specified component / analyte, organism or clinical sign based on the established threshold of the performed test or procedure.\r\n\n [Note: Negative does not necessarily imply the complete absence of the specified item.]"; 645 case ND: return "The presence of the specified component / analyte, organism or clinical sign could not be determined within the limit of detection of the performed test or procedure."; 646 case POS: return "A presence finding of the specified component / analyte, organism or clinical sign based on the established threshold of the performed test or procedure."; 647 case DET: return "The measurement of the specified component / analyte, organism or clinical sign above the limit of detection of the performed test or procedure."; 648 case OBSERVATIONINTERPRETATIONEXPECTATION: return "Interpretation of the observed result taking into account additional information (contraindicators) about the patient's situation. Concepts in this category are mutually exclusive, i.e., at most one is allowed."; 649 case EXP: return "This result has been evaluated in light of known contraindicators. Once those contraindicators have been taken into account the result is determined to be \"Expected\" (e.g., presence of drugs in a patient that is taking prescription medication for pain management)."; 650 case UNE: return "This result has been evaluated in light of known contraindicators. Once those contraindicators have been taken into account the result is determined to be \"Unexpected\" (e.g., presence of non-prescribed drugs in a patient that is taking prescription medication for pain management)."; 651 case OBX: return "Interpretation qualifiers in separate OBX segments\r\n\n \n Usage Note: This code is not intended for use in V3 artifacts. It is included in the code system to maintain alignment with the V2 Table 0078 \"Interpretation Codes.\""; 652 case REACTIVITYOBSERVATIONINTERPRETATION: return "Interpretations of the presence and level of reactivity of the specified component / analyte with the reagent in the performed laboratory test."; 653 case NR: return "An absence finding used to indicate that the specified component / analyte did not react measurably with the reagent."; 654 case RR: return "A presence finding used to indicate that the specified component / analyte reacted with the reagent above the reliably measurable limit of the performed test."; 655 case WR: return "A weighted presence finding used to indicate that the specified component / analyte reacted with the reagent, but below the reliably measurable limit of the performed test."; 656 default: return "?"; 657 } 658 } 659 public String getDisplay() { 660 switch (this) { 661 case _GENETICOBSERVATIONINTERPRETATION: return "GeneticObservationInterpretation"; 662 case CAR: return "Carrier"; 663 case CARRIER: return "Carrier"; 664 case _OBSERVATIONINTERPRETATIONCHANGE: return "ObservationInterpretationChange"; 665 case B: return "Better"; 666 case D: return "Significant change down"; 667 case U: return "Significant change up"; 668 case W: return "Worse"; 669 case _OBSERVATIONINTERPRETATIONEXCEPTIONS: return "ObservationInterpretationExceptions"; 670 case LESS_THAN: return "Off scale low"; 671 case GREATER_THAN: return "Off scale high"; 672 case AC: return "Anti-complementary substances present"; 673 case IE: return "Insufficient evidence"; 674 case QCF: return "Quality control failure"; 675 case TOX: return "Cytotoxic substance present"; 676 case _OBSERVATIONINTERPRETATIONNORMALITY: return "ObservationInterpretationNormality"; 677 case A: return "Abnormal"; 678 case AA: return "Critical abnormal"; 679 case HH: return "Critical high"; 680 case LL: return "Critical low"; 681 case H: return "High"; 682 case H_: return "Significantly high"; 683 case HU: return "Significantly high"; 684 case L: return "Low"; 685 case L_: return "Significantly low"; 686 case LU: return "Significantly low"; 687 case N: return "Normal"; 688 case _OBSERVATIONINTERPRETATIONSUSCEPTIBILITY: return "ObservationInterpretationSusceptibility"; 689 case I: return "Intermediate"; 690 case MS: return "moderately susceptible"; 691 case NS: return "Non-susceptible"; 692 case R: return "Resistant"; 693 case SYNR: return "Synergy - resistant"; 694 case S: return "Susceptible"; 695 case SDD: return "Susceptible-dose dependent"; 696 case SYNS: return "Synergy - susceptible"; 697 case VS: return "very susceptible"; 698 case EX: return "outside threshold"; 699 case HX: return "above high threshold"; 700 case LX: return "below low threshold"; 701 case HM: return "Hold for Medical Review"; 702 case OBSERVATIONINTERPRETATIONDETECTION: return "ObservationInterpretationDetection"; 703 case IND: return "Indeterminate"; 704 case E: return "Equivocal"; 705 case NEG: return "Negative"; 706 case ND: return "Not detected"; 707 case POS: return "Positive"; 708 case DET: return "Detected"; 709 case OBSERVATIONINTERPRETATIONEXPECTATION: return "ObservationInterpretationExpectation"; 710 case EXP: return "Expected"; 711 case UNE: return "Unexpected"; 712 case OBX: return "Interpretation qualifiers in separate OBX segments"; 713 case REACTIVITYOBSERVATIONINTERPRETATION: return "ReactivityObservationInterpretation"; 714 case NR: return "Non-reactive"; 715 case RR: return "Reactive"; 716 case WR: return "Weakly reactive"; 717 default: return "?"; 718 } 719 } 720 721 722} 723